Arcus Free Cash Flow from 2010 to 2025

RCUS Stock  USD 10.89  1.01  10.22%   
Arcus Biosciences Free Cash Flow yearly trend continues to be comparatively stable with very little volatility. Free Cash Flow is likely to outpace its year average in 2025. Free Cash Flow is the amount of cash Arcus Biosciences generates after accounting for cash outflows to support operations and maintain its capital assets. View All Fundamentals
 
Free Cash Flow  
First Reported
2017-03-31
Previous Quarter
25 M
Current Value
-101 M
Quarterly Volatility
134.1 M
 
Covid
Check Arcus Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Arcus Biosciences' main balance sheet or income statement drivers, such as Net Interest Income of 50.4 M, Interest Income of 54.6 M or Depreciation And Amortization of 6.7 M, as well as many indicators such as Price To Sales Ratio of 4.94, Dividend Yield of 0.0 or PTB Ratio of 3.36. Arcus financial statements analysis is a perfect complement when working with Arcus Biosciences Valuation or Volatility modules.
  
Check out the analysis of Arcus Biosciences Correlation against competitors.
For more information on how to buy Arcus Stock please use our How to Invest in Arcus Biosciences guide.

Latest Arcus Biosciences' Free Cash Flow Growth Pattern

Below is the plot of the Free Cash Flow of Arcus Biosciences over the last few years. It is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets. Arcus Biosciences' Free Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Arcus Biosciences' overall financial position and show how it may be relating to other accounts over time.
Free Cash Flow10 Years Trend
Pretty Stable
   Free Cash Flow   
       Timeline  

Arcus Free Cash Flow Regression Statistics

Arithmetic Mean(43,333,375)
Geometric Mean54,280,700
Coefficient Of Variation(386.82)
Mean Deviation102,196,844
Median(17,043,000)
Standard Deviation167,621,076
Sample Variance28096.8T
Range756M
R-Value(0.22)
Mean Square Error28685.9T
R-Squared0.05
Significance0.42
Slope(7,640,862)
Total Sum of Squares421452.4T

Arcus Free Cash Flow History

2025-167.2 M
2024-176 M
2023-330 M
2022426 M
2021-282.2 M
2020108.1 M
2019-75.4 M

Other Fundumenentals of Arcus Biosciences

Arcus Biosciences Free Cash Flow component correlations

About Arcus Biosciences Financial Statements

Arcus Biosciences shareholders use historical fundamental indicators, such as Free Cash Flow, to determine how well the company is positioned to perform in the future. Although Arcus Biosciences investors may analyze each financial statement separately, they are all interrelated. The changes in Arcus Biosciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on Arcus Biosciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Free Cash Flow-176 M-167.2 M
Free Cash Flow Yield(0.13)(0.12)
Free Cash Flow Per Share(1.95)(1.86)
EV To Free Cash Flow(7.04)(7.40)
Price To Free Cash Flows Ratio(7.62)(8.00)
Free Cash Flow Operating Cash Flow Ratio 1.04  1.20 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Arcus Stock Analysis

When running Arcus Biosciences' price analysis, check to measure Arcus Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcus Biosciences is operating at the current time. Most of Arcus Biosciences' value examination focuses on studying past and present price action to predict the probability of Arcus Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcus Biosciences' price. Additionally, you may evaluate how the addition of Arcus Biosciences to your portfolios can decrease your overall portfolio volatility.